Search Results - "Gibson, Amber"
-
1
-
2
Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing
Published in BMC cancer (31-05-2023)“…Single-cell RNA-seq has emerged as an innovative technology used to study complex tissues and characterize cell types, states, and lineages at a single-cell…”
Get full text
Journal Article -
3
Rare Case of Hybrid Oncocytoma and Chromophobe Renal Cell Carcinoma in a Pediatric Patient
Published in Pediatric blood & cancer (01-06-2016)Get full text
Journal Article -
4
Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia
Published in Blood (02-11-2023)“…Ataxia Telangiectasia (AT) is an autosomal recessive disorder which is associated with progressive neurodegeneration, immunodeficiency, and predisposition to…”
Get full text
Journal Article -
5
Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy
Published in Pediatric blood & cancer (01-09-2024)Get full text
Journal Article -
6
Neither iatrogenic nor hereditary cause: A rare case of anaphylaxis to low sorb tubing used for infusions
Published in Pediatric blood & cancer (01-04-2021)Get full text
Journal Article -
7
RARE-44. CLINICAL CHARACTERIZATION AND OUTCOME; OUR EXPERIENCE OF CHORDOMAS IN PEDIATRIC AND YOUNG ADULTS
Published in Neuro-oncology (Charlottesville, Va.) (04-12-2020)“…Abstract Pediatric chordomas are exceedingly rare and there are limited data to guide treatment decisions. We report a retrospective analysis of 19 patients…”
Get full text
Journal Article -
8
Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
Published in Pediatric blood & cancer (01-11-2024)“…This retrospective study at the University of Texas MD Anderson Cancer Center evaluated frontline venetoclax combination therapy in 11 pediatric/adolescent…”
Get full text
Journal Article -
9
Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen
Published in Pediatric blood & cancer (01-08-2024)Get full text
Journal Article -
10
Once-daily Compared With Twice-daily Enoxaparin Maintenance Therapy Appears Safe and Efficacious in Pediatric Venous Thromboembolism
Published in Journal of pediatric hematology/oncology (01-07-2023)“…Once-daily enoxaparin (ODE), considered standard of care for venous thromboembolism (VTE) treatment in adults, has been infrequently assessed in children. To…”
Get full text
Journal Article -
11
-
12
EAPH-15. COMBINATION THERAPY WITH VINCRISTINE, IRINOTECAN, AND TEMOZOLOMIDE IN CENTRAL NERVOUS SYSTEM MALIGNANCIES
Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)“…Abstract Current therapeutic options for high grade gliomas including DIPG (HGG) and relapsed or refractory CNS malignancies (R-CNS), excluding low grade…”
Get full text
Journal Article -
13
Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia
Published in Pediatric blood & cancer (01-08-2024)Get full text
Journal Article -
14
-
15
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Published in Leukemia (01-09-2023)“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that can involve the bone marrow, peripheral blood, skin, lymph nodes,…”
Get full text
Journal Article -
16
Non‐myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita
Published in Pediatric transplantation (01-03-2022)“…Background Short telomere syndrome (STS) in children may result in phenotypically heterogenous clinical spectrum ranging from completely asymptomatic to…”
Get full text
Journal Article -
17
Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Published in Blood (02-11-2023)“…Background: The interaction of menin with lysine methyltransferase 2A (KMT2A) is a dependency in acute leukemia caused by either rearrangement of the KMT2A…”
Get full text
Journal Article -
18
Pembrolizumab in Combination with Antigen-Specific Cytotoxic T Lymphocytes Enhances Killing of Acute Myeloid Leukemia
Published in Blood (23-11-2021)“…Background Pembrolizumab, an antibody that blocks programmed cell death protein 1 (PD-1), has been FDA approved for several solid tumors and hematologic…”
Get full text
Journal Article -
19
Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm
Published in Journal of pediatric hematology/oncology (01-11-2023)“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy, especially in pediatrics, that can involve the bone marrow, skin, lymph…”
Get full text
Journal Article -
20
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Published in Cancers (29-12-2021)“…Venetoclax is approved for adult patients with chronic lymphocytic leukemia and acute myeloid leukemia. Expanding its use to the pediatric population is…”
Get full text
Journal Article